Background: The prevalence of the obstructive sleep apnea syndrome is
about 5% in the entire population. The amount of treatment-indications
grows for this particular sleep-related breathing disorder due to the
increasing usage of diagnostic screening tests. In most cases, the po
sitive-pressure ventilation, PPV (nCPAP, nBiPAP(R)) is considered as a
highly effective form of treatment, in comparison to other treating m
ethods. The residential polysomnographic supervised adjustment of the
treatment is optimally applied to most of the patients. Due to the inc
reasing number of the treated patients, the reports about the appearan
ce of short-termed side effects during the adjustment of the PPV becom
e more frequent. Patients and Results: We report on 9 patients who sho
wed complications during the initial stage of treatment. The most comm
on one, during the nCPAP-therapy; was the increase of central apneas.
Because of this complication, a rapid optimization of the respiratory
pressure or a change to a nBiPAP(R)-therapy was necessary in 5 of the
patients. 2 of the patients showed cardiac arrhythmias, some of which
were severe. One patient produced a remarkable central hypoventilation
during the initial phase of a nCPAP-therapy. The nBiPAP(R)-titration
combined with right-heart-catheter monitoring could demonstrate in ano
ther patient a possible cardiac decompensation through an increased ve
ntilatory pressure.Conclusion: The risk of a positive-pressure ventila
tion is higher in patients with accompanying cardiac, pulmonary neurop
sychiatric and/or otorhinolaryngologic disorders. Considering the vari
ous predisposing factors of the patients we suggest an intensive appar
ative monitoring as well as stuff-supervision during the introduction
to a respiratory treatment. If complications appear, a rapid improveme
nt of the ventilatory pressure or a change to another respiratory trea
tment is indicated.